참고문헌 (92)

1. Abenavoli , L. , Capasso , R. , Milic , N. , & Capasso , F. ( 2010 ). Milk thistle in liver diseases: Past, present, future . Phytotherapy Research , 24 , 1423 – 1432 . https://doi.org/10.1002/ptr.3207 

   상세보기

2. Agarwal , R. , Agarwal , C. , Ichikawa , H. , Singh , R. P. , & Aggarwal , B. B. ( 2006 ). Anticancer potential of silymarin: From bench to bed side . Anticancer Research , 26 ( 6B ), 4457 – 4498 . 

3. Aller , R. , Izaola , O. , Gómez , S. , Tafur , C. , González , G. , Berroa , E. , … de Luis , D. A. ( 2015 ). Effect of silymarin plus vitamin E in patients with non‐alcoholic fatty liver disease. A randomized clinical pilot study . European Review for Medical and Pharmacological Sciences , 19 ( 16 ), 3118 – 3124 . 

   상세보기

4. Anwar , S. , Madkor , H. R. , Ahmed , N. , & Wagih , M. E. ( 2018 ). In vivo anticlastogenic effect of silymarin from milk thistle Silybum marianum L . Indian Journal of Pharmacology , 50 ( 3 ), 108 – 115 . 

   상세보기

5. Baghbahadorani , F. K. , & Miraj , S. ( 2017 ). The impact of silymarin on improvement of hepatic abnormalities in patients with severe preeclampsia: A randomized clinical trial . Electronic Physician , 9 ( 8 ), 5098 – 5106 . https://doi.org/10.19082/5098 

   상세보기

6. Bakhshaee , M. , Jabbari , F. , Hoseini , S. , Farid , R. , Sadeghian , M. H. , Rajati , M. , … Zamani , M. A. ( 2011 ). Effect of silymarin in the treatment of allergic rhinitis . Otolaryngology–Head and Neck Surgery , 145 ( 6 ), 904 – 909 . https://doi.org/10.1177/0194599811423504 

   상세보기

7. Balouchi , S. , Gharagozloo , M. , Esmaeil , N. , Mirmoghtadaei , M. , & Moayedi , B. ( 2014 ). Serum levels of TGFβ, IL‐10, IL‐17, and IL‐23 cytokines in β‐thalassemia major patients: The impact of silymarin therapy . Immunopharmacology and Immunotoxicology , 36 ( 4 ), 271 – 274 . https://doi.org/10.3109/08923973.2014.926916 

   상세보기

8. Bazzano , A. N. , Hofer , R. , Thibeau , S. , Gillispie , V. , Jacobs , M. , & Theall , K. P. ( 2016 ). A review of herbal and pharmaceutical galactagogues for breast‐feeding . The Ochsner Journal , 16 ( 4 ), 511 – 524 . 

9. Becker‐Schiebe , M. , Mengs , U. , Schaefer , M. , Bulitta , M. , & Hoffmann , W. ( 2011 ). Topical use of a silymarin‐based preparation to prevent radiodermatitis: Results of a prospective study in breast cancer patients . Strahlentherapie und Onkologie , 187 ( 8 ), 485 – 491 . 

   상세보기

10. Beckmann‐Knopp , S. , Rietbrock , S. , Weyhenmeyer , R. , Böcker , R. H. , Beckurts , K. T. , Lang , W. , … Fuhr , U. ( 2000 ). Inhibitory effects of silibinin on cytochrome P‐450 enzymes in human liver microsomes . Pharmacology & Toxicology , 86 ( 6 ), 250 – 256 . 

    상세보기

11. Belli , V. , Sforza , V. , Cardone , C. , Martinelli , E. , Barra , G. , Matrone , N. , … Troiani , T. ( 2017 ). Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer . Oncotarget , 8 ( 40 ), 68305 – 68316 . 

12. Biermer , M. , Schlosser , B. , Fülöp , B. , van Bömmel , F. , Brodzinski , A. , Heyne , R. , … Berg , T. ( 2012 ). High‐dose silibinin rescue treatment for HCV‐infected patients showing suboptimal virologic response to standard combination therapy . Journal of Viral Hepatitis , 19 ( 8 ), 547 – 553 . https://doi.org/10.1111/j.1365‐2893.2011.01572.x 

    상세보기

13. Bijak , M. ( 2017 ). Silybin, a major bioactive component of milk thistle ( Silybum marianum L. gaernt.)‐chemistry, bioavailability and metabolism . Molecules , 22 ( 11 ). https://doi.org/10.3390/molecules22111942 

    상세보기

14. Bijak , M. , Synowiec , E. , Sitarek , P. , Sliwiński , T. , & Saluk‐Bijak , J. ( 2017 ). Evaluation of the cytotoxicity and genotoxicity of flavonolignans in different cellular models . Nutrients , 9 ( 12 ), 1356 . https://doi.org/10.3390/nu9121356 

    상세보기

15. Brandon‐Warner , E. , Eheim , A. L. , Foureau , D. M. , Walling , T. L. , Schrum , L. W. , & McKillop , I. H. ( 2012 ). Silibinin (Milk Thistle) potentiates ethanol‐dependent hepatocellular carcinoma progression in male mice . Cancer Letters , 326 ( 1 ), 88 – 95 . https://doi.org/10.1016/j.canlet.2012.07.028 

    상세보기

16. Brantley , S. J. , Oberlies , N. H. , Kroll , D. J. , & Paine , M. F. ( 2010 ). Two flavonolignans from milk thistle ( Silybum marianum ) inhibit CYP2C9‐mediated warfarin metabolism at clinically achievable concentrations . Journal of Pharmacology and Experimental Therapeutics , 332 ( 3 ), 1081 – 1087 . https://doi.org/10.1124/jpet.109.161927 

    상세보기

17. Capasso , R. , Aviello , G. , & Capasso , F. ( 2009 ). Silymarin BIO‐C®, an extract from Silybum marianum fruits, induces hyper‐prolactinemia in intact female rats . Phytomedicine , 16 , 839 – 844 . https://doi.org/10.1016/j.phymed.2009.02.007 

    상세보기

18. Darvishi Khezri , H. , Salehifar , E. , Kosaryan , M. , Aliasgharian , A. , Jalali , H. , & Hadian Amree , A. ( 2016 ). Potential effects of silymarin and its flavonolignan components in patients with β‐Thalassemia Major: A comprehensive review in 2015 . Advances in Pharmacological Sciences , 2016 , 3046373 . 

19. Di Pierro , F. , Bellone , I. , Rapacioli , G. , & Putignano , P. ( 2015 ). Clinical role of a fixed combination of standardized Berberis aristata and Silybum marianum extracts in diabetic and hypercholesterolemic patients intolerant to statins . Diabetes, Metabolic Syndrome and Obesity , 8 , 89 – 96 . 

    상세보기

20. Di Pierro , F. , Callegari , A. , Carotenuto , D. , & Tapia , M. M. ( 2008 ). Clinical efficacy, safety and tolerability of BIO‐C (micronized Silymarin) as a galactagogue . Acta BioMedica , 79 ( 3 ), 205 – 210 . 

21. Di Pierro , F. , Putignano , P. , Villanova , N. , Montesi , L. , Moscatiello , S. , & Marchesini , G. ( 2013 ). Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes . Clinical Pharmacology , 5 , 167 – 174 . https://doi.org/10.2147/CPAA.S54308 

    상세보기

22. Dixit , N. , Baboota , S. , Kohli , K. , Ahmad , S. , & Ali , J. ( 2007 ). Silymarin: A review of pharmacological aspects and bioavailability enhancement approaches . Indian Journal of Pharmacology , 39 , 172 – 179 . https://doi.org/10.4103/0253‐7613.36534 

    상세보기

23. Dunnick , J. K. , Nyska , A. , Bishop , J. B. , Bucher , J. R. , Chhabra , R. S. , Foster , P. M. , … Serbus , D. C. ( 2011 ). Toxicology and carcinogenesis studies of milk thistle extract (CAS No. 84604–20‐6) in F344/N rats and B6C3F1 mice (Feed Studies) . National Toxicology Program Technical Report Series , 565 , 1 – 177 . 

24. Ebrahimpour Koujan , S. , Gargari , B. P. , Mobasseri , M. , Valizadeh , H. , & Asghari‐Jafarabadi , M. ( 2015 ). Effects of Silybum marianum (L.) Gaertn. (silymarin) extract supplementation on antioxidant status and hs‐CRP in patients with type 2 diabetes mellitus: A randomized, triple‐blind, placebo‐controlled clinical trial . Phytomedicine , 22 ( 2 ), 290 – 296 . https://doi.org/10.1016/j.phymed.2014.12.010 

    상세보기

25. El‐Kamary , S. S. , Shardell , M. D. , Abdel‐Hamid , M. , Ismail , S. , El‐Ateek , M. , Metwally , M. , … Strickland , G. T. ( 2009 ). A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis . Phytomedicine , 16 ( 5 ), 391 – 400 . https://doi.org/10.1016/j.phymed.2009.02.002 

    상세보기

26. Elyasi , S. , Hosseini , S. , Niazi Moghadam , M. R. , Aledavood , S. A. , & Karimi , G. ( 2016 ). Effect of oral silymarin administration on prevention of radiotherapy induced mucositis: A randomized, double‐blinded, placebo‐controlled clinical trial . Pythotherapy Research , 30 ( 11 ), 1879 – 1885 . https://doi.org/10.1002/ptr.5704 

    상세보기

27. Elyasi , S. , Shojaee , F. S. R. , Allahyari , A. , & Karimi , G. ( 2017 ). Topical silymarin administration for prevention of capecitabine‐induced hand‐foot syndrome: A randomized, double‐blinded, placebo‐controlled clinical trial . Phytotherapy Research , 31 ( 9 ), 1323 – 1329 . https://doi.org/10.1002/ptr.5857 

    상세보기

28. Evren , E. , & Yurtcu , E. ( 2015 ). In vitro effects on biofilm viability and antibacterial and antiadherent activities of silymarin . Folia Microbiologica , 60 ( 4 ), 351 – 356 . https://doi.org/10.1007/s12223‐015‐0399‐6 

    상세보기

29. Fallahzadeh , M. K. , Dormanesh , B. , Sagheb , M. M. , Roozbeh , J. , Vessal , G. , Pakfetrat , M. , … Lankarani , K. B. ( 2012 ). Effect of addition of silymarin to renin‐angiotensin system inhibitors on proteinuria in type 2 diabetic patients with overt nephropathy: a randomized, double‐blind, placebo‐controlled trial . American Journal of Kidney Diseases , 60 ( 6 ), 896 – 903 . https://doi.org/10.1053/j.ajkd.2012.06.005 

    상세보기

30. Federico , A. , Dallio , M. , & Loguercio , C. ( 2017 ). Silymarin/silybin and chronic liver disease: A marriage of many years . Molecules , 22 ( 2 ), pii: E191 . 

    상세보기

31. Ferenci , P. , Dragosics , B. , Dittrich , H. , Frank , H. , Benda , L. , Lochs , H. , Meryn , S. , Base , W. , & Schneider , B. ( 1989 ). Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver . J Hepatol , 9 ( 1 ): 105 – 13 . 

    상세보기

32. Flaig , T. W. , Gustafson , D. L. , Su , L. J. , Zirrolli , J. A. , Crighton , F. , Harrison , G. S. , … Glodé , L. M. ( 2007 ). A phase I and pharmacokinetic study of silybin‐phytosome in prostate cancer patients . Investigational New Drugs , 25 ( 2 ), 139 – 146 . https://doi.org/10.1007/s10637‐006‐9019‐2 

    상세보기

33. Fogacci , F. , Grassi , D. , Rizzo , M. , & Cicero , A. F. G. ( 2019 ). Metabolic effect of berberine‐silymarin association: A meta‐analysis of randomized, double‐blind, placebo‐controlled clinical trials . Phytotherapy Research . https://doi.org/10.1002/ptr.6282 

    상세보기

34. Forghani , P. , Khorramizadeh , M. R. , & Waller , E. K. ( 2014 ). Silibinin inhibits accumulation of myeloid‐derived suppressor cells and tumor growth of murine breast cancer . Cancer Medicine , 3 ( 2 ), 215 – 224 . https://doi.org/10.1002/cam4.186 

    상세보기

35. Fried , M. W. , Navarro , V. J. , Afdhal , N. , Belle , S. H. , Wahed , A. S. , Hawke , R. L. , … Reddy , K. R. ( 2012 ). Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: A randomized controlled trial . JAMA , 308 ( 3 ), 274 – 282 . https://doi.org/10.1001/jama.2012.8265 

    상세보기

36. Gholami , M. , Moallem , S. A. , Afshar , M. , Amoueian , S. , Etemad , L. , & Karimi , G. ( 2016 ). Teratogenic effects of silymarin on mouse fetuses . Avicenna Journal of Phytomedicine , 6 ( 5 ), 542 – 549 . 

37. Hagag , A. A. , Elfaragy , M. S. , Elrifaey , S. M. , & Abd El‐Lateef , A. E. ( 2015 ). Therapeutic value of combined therapy with deferiprone and silymarin as iron chelators in Egyptian children with beta thalassemia major . Infectious Disorders Drug Targets , 15 ( 3 ), 189 – 195 . https://doi.org/10.2174/1871526515666150731113305 

    상세보기

38. Hawke , R. L. , Schrieber , S. J. , Soule , T. A. , Wen , Z. , Smith , P. C. , Reddy , K. R. , … Fried , M. W. ( 2010 ). Silymarin ascending multiple oral dosing phase I study in noncirrhotic patients with chronic hepatitis C . Journal of Clinical Pharmacology , 50 ( 4 ), 434 – 449 . https://doi.org/10.1177/0091270009347475 

    상세보기

39. Heo , E. , Kim , D. K. , Oh , S. H. , Lee , J. K. , Park , J. H. , & Chung , H. S. ( 2017 ). Effect of prophylactic use of silymarin on anti‐tuberculosis drugs induced hepatotoxicity . Tuberculosis Respiratory Disease , 80 ( 3 ), 265 – 269 . https://doi.org/10.4046/trd.2017.80.3.265 

    원문보기 상세보기

40. Hung , J. H. , Chu , C. J. , Sung , P. L. , Chen , C. Y. , Chao , K. C. , Yang , M. J. , & Hung , S. C. ( 2008 ). Lamivudine therapy in the treatment of chronic hepatitis B with acute exacerbation during pregnancy . Journal of the Chinese Medical Association , 71 ( 3 ), 155 – 158 . https://doi.org/10.1016/S1726‐4901(08)70009‐1 

    상세보기

41. Hussain , S. A. ( 2007 ). Silymarin as an adjunct to glibenclamide therapy improves long‐term and postprandial glycemic control and body mass index in type 2 diabetes . Journal of Medicinal Food , 10 ( 3 ), 543 – 547 . https://doi.org/10.1089/jmf.2006.089 

    상세보기

42. Hussain , S. A. , Jassim , N. A. , Numan , I. T. , Al‐Khalifa , I. I. , & Abdullah , T. A. ( 2009 ). Anti‐inflammatory activity of silymarin in patients with knee osteoarthritis. A comparative study with piroxicam and meloxicam . Saudi Medical Journal , 30 ( 1 ), 98 – 103 . 

    상세보기

43. Hussain , S. A. , Mortada , A. H. , Jasim , N. A. , & Gorial , F. I. ( 2016 ). Silibinin improves the effects of methotrexate in patients with active rheumatoid arthritis: Pilot clinical study . Oman Medical Journal , 31 ( 4 ), 263 – 269 . https://doi.org/10.5001/omj.2016.52 

    

44. Hutchinson , C. , Bomford , A. , & Geissler , A. C. ( 2010 ). The iron‐chelating potential of silybin in patients with hereditary haemochromatosis . European Journal of Clinical Nutrition , 64 ( 10 ), 1239 – 1241 . https://doi.org/10.1038/ejcn.2010.136 

    상세보기

45. Kalantari , H. , Shahshahan , Z. , Hejazi , S. M. , Ghafghazi , T. , & Sebghatolahi , V. ( 2011 ). Effects of Silybum marianum on patients with chronic hepatitis C . Journal of Research in Medical Sciences , 16 ( 3 ), 287 – 290 . 

    상세보기

46. Karbasforooshan , H. , Hosseini , S. , Elyasi , S. , Fani Pakdel , A. , & Karimi , G. ( 2018 ). Topical silymarin administration for prevention of acute radiodermatitis in breast cancer patients: A randomized, double‐blind, placebo‐controlled clinical trial . Phytoyherapy Research , 33 , 379 – 386 . https://doi.org/10.1002/ptr.6231 

    상세보기

47. Karimi , G. , Hassanzadeh‐Josan , S. , Memar , B. , Esmaeili , S. A. , & Riahi‐Zanjani , B. ( 2018 ). Immunomodulatory effects of silymarin after subacute exposure to mice: A tiered approach immunotoxicity screening . Journal of Pharmacopuncture , 21 ( 2 ), 90 – 97 . https://doi.org/10.3831/KPI.2018.21.011 

    원문보기 상세보기

48. Karimi , G. , Vahabzadeh , M. , Lari , P. , Rashedinia , M. , & Moshiri , M. ( 2011 ). "Silymarin", a promising pharmacological agent for treatment of diseases . Iranian Journal of Basic Medical Sciences , 14 ( 4 ), 308 – 317 . 

    상세보기

49. Katiyar , S. K. , Mantena , S. K. , & Meeran , S. M. ( 2011 ). Silymarin protects epidermal keratinocytes from ultraviolet radiation‐induced apoptosis and DNA damage by nucleotide excision repair mechanism . PLoS ONE , 6 ( 6 ), e21410 . https://doi.org/10.1371/journal.pone.0021410 

    상세보기

50. Katiyar , S. K. , Meleth , S. , & Sharma , S. D. ( 2008 ). Silymarin, a flavonoid from milk thistle ( Silybum marianum L.), inhibits UV‐induced oxidative stress through targeting infiltrating CD11b+ cells in mouse skin . Photochemistry and Photobiology , 84 ( 2 ), 266 – 271 . https://doi.org/10.1111/j.1751‐1097.2007.00241.x 

    상세보기

51. Kawaguchi‐Suzuki , M. , Frye , R. F. , Zhu , H. J. , Brinda , B. J. , Chavin , K. D. , Bernstein , H. J. , & Markowitz , J. S. ( 2014 ). The effects of milk thistle ( Silybum marianum ) on human cytochrome P450 activity . Drug Metabolism and Disposition , 42 ( 10 ), 1611 – 1616 . https://doi.org/10.1124/dmd.114.057232 

    상세보기

52. Khazim , K. , Gorin , Y. , Cavaglieri , R. C. , Abboud , H. E. , & Fanti , P. ( 2013 ). The antioxidant silybin prevents high glucose‐induced oxidative stress and podocyte injury in vitro and in vivo . American Journal of Physiology ‐ Renal Physiology , 305 ( 5 ), F691 – F700 . https://doi.org/10.1152/ajprenal.00028.2013 

    상세보기

53. Ladas , E. J. , Kroll , D. J. , Oberlies , N. H. , Cheng , B. , Ndao , D. H. , Rheingold , S. R. , & Kelly , K. M. ( 2010 ). A randomized, controlled, double‐blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL) . Cancer , 116 ( 2 ), 506 – 513 . https://doi.org/10.1002/cncr.24723 

    상세보기

54. Lani , R. , Hassandarvish , P. , Chiam , C. W. , Moghaddam , E. , Jang Hann Chu , J. , Rausalu , K. , … Zandi , K. ( 2015 ). Antiviral activity of silymarin against chikungunya virus . Scientific Reports , 5 , 11421 . https://doi.org/10.1038/srep11421 

    상세보기

55. Leber , H. W. , & Knauff , S. ( 1976 ). Influence of silymarin on drug metabolizing enzymes in rat and man . Arzneimittel‐Forschung , 26 ( 8 ), 1603 – 1605 . 

56. Loguercio , C. , Andreone , P. , Brisc , C. , Brisc , M. C. , Bugianesi , E. , Chiaramonte , M. , … Federico , A. ( 2012 ). Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial . Free Radical Biology & Medicine , 52 ( 9 ), 1658 – 1665 . https://doi.org/10.1016/j.freeradbiomed.2012.02.008 

    상세보기

57. Luangchosiri , C. , Thakkinstian , A. , Chitphuk , S. , Stitchantrakul , W. , Petraksa , S. , & Sobhonslidsuk , A. ( 2015 ). A double‐blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug‐induced liver injury . BMC Complementary and Alternative Medicine , 15 , 334 . https://doi.org/10.1186/s12906‐015‐0861‐7 

    상세보기

58. Luper , S. ( 1998 ). A review of plants used in the treatment of liver disease: Part 1 . Alternative Medicine Review , 3 ( 6 ), 410 – 421 . 

    상세보기

59. Mady , F. M. , Hanaa Essa , H. , El‐Ammawi , T. , Abdelkader , H. , & Hussein , A. K. ( 2016 ). Formulation and clinical evaluation of silymarin pluronic‐lecithin organogels for treatment of atopic dermatitis . Drug Design, Development and Therapy , 10 , 1101 – 1110 . 

60. Malaguarnera , G. , Bertino , G. , Chisari , G. , Motta , M. , Vecchio , M. , Vacante , M. , … Malaguarnera , M. ( 2016 ). Silybin supplementation during HCV therapy with pegylated interferon‐α plus ribavirin reduces depression and anxiety and increases work ability . BMC Psychiatry , 16 ( 1 ), 398 . https://doi.org/10.1186/s12888‐016‐1115‐z 

    상세보기

61. Marin , V. , Gazzin , S. , Gambaro , S. E. , Dal , B. M. , Calligaris , S. , Anese , M. , … Rosso , N. ( 2017 ). Effects of oral administration of silymarin in a juvenile murine model of non‐alcoholic steatohepatitis . Nutrients , 9 ( 9 ), 1006 . https://doi.org/10.3390/nu9091006 

    상세보기

62. Marjani , M. , Baghaei , P. , Kazempour Dizaji , M. , Gorji Bayani , P. , Fahimi , F. , Tabarsi , P. , & Velayati , A. A. ( 2016 ). Evaluation of hepatoprotective effect of silymarin among under treatment tuberculosis patients: A randomized clinical trial . Iranian Journal of Pharmaceutical Research , 15 ( 1 ), 247 – 252 . 

63. Mengs , U. , Pohl , R. T. , & Mitchell , T. ( 2012 ). Legalon® SIL: The antidote of choice in patients with acute hepatotoxicity from amatoxin poisoning . Current Pharmaceutical Biotechnology , 13 ( 10 ), 1964 – 1970 . https://doi.org/10.2174/138920112802273353 

    상세보기

64. Moayedi , B. , Gharagozloo , M. , Esmaeil , N. , Maracy , M. R. , Hoorfar , H. , & Jalaeikar , M. ( 2013 ). A randomized double‐blind, placebo‐controlled study of therapeutic effects of silymarin in β‐thalassemia major patients receiving desferrioxamine . European Journal of Haematology , 90 ( 3 ), 202 – 209 . https://doi.org/10.1111/ejh.12061 

    상세보기

65. Moltó , J. , Valle , M. , Miranda , C. , Cedeño , S. , Negredo , E. , & Clotet , B. ( 2012 ). Effect of milk thistle on the pharmacokinetics of darunavir‐ritonavir in HIV‐infected patients . Antimicrobial Agents and Chemotherapy , 56 ( 6 ), 2837 – 2841 . https://doi.org/10.1128/AAC.00025‐12 

    상세보기

66. Momeni , A. , Hajigholami , A. , Geshnizjani , S. , & Soleiman , K. ( 2015 ). Effect of silymarin in the prevention of cisplatin nephrotoxicity, a clinical trial Study . Journal of Clinical and Diagnostic Research , 9 ( 4 ), OC11 – OC13 . https://doi.org/10.7860/JCDR/2015/12776.5789 

    상세보기

67. Napolitano , J. G. , Lankin , D. C. , Graf , T. N. , Friesen , J. B. , Chen , S. N. , McAlpine , J. B. , … Pauli , G. F. ( 2013 ). HiFSA fingerprinting applied to isomers with near‐Identical NMR spectra: The silybin/isosilybin case . Journal of Organic Chemistry , 78 ( 7 ), 2827 – 2839 . https://doi.org/10.1021/jo302720h 

    상세보기

68. Nazemian , F. , Karimi , G. , Moatamedi , M. , Charkazi , S. , Shamsara , J. , & Mohammadpour , A. H. ( 2010 ). Effect of silymarin administration on TNF‐α serum concentration in peritoneal dialysis patients . Phytotherapy Research , 24 ( 11 ), 1654 – 1657 . https://doi.org/10.1002/ptr.3175 

    상세보기

69. Negi , A. S. , Kumar , J. K. , Luqman , S. , Shanker , K. , Gupta , M. M. , & Khanuja , S. P. ( 2008 ). Recent advances in plant hepatoprotectives: A chemical and biological profile of some important leads . Medicinal Research Reviews , 28 ( 5 ), 746 – 772 . https://doi.org/10.1002/med.20115 

    상세보기

70. Papackova , Z. , Heczkova , M. , Dankova , H. , Sticova , E. , Lodererova , A. , Bartonova , L. , … Cahova , M. ( 2018 ). Silymarin prevents acetaminophen‐induced hepatotoxicity in mice . PLoS ONE , 13 ( 1 ), e0191353 . https://doi.org/10.1371/journal.pone.0191353 

    상세보기

71. Polyak , S. J. , Ferenci , P. , & Pawlotsky , J. M. ( 2013 ). Hepatoprotective and antiviral functions of silymarin components in HCV infection . Hepatology , 57 ( 3 ), 1262 – 1271 . https://doi.org/10.1002/hep.26179 

    상세보기

72. Rafieian‐Kopaie , M. , & Nasri , H. ( 2012 ). Silymarin and diabetic nephropathy . Journal of Renal Injury Prevention , 1 ( 1 ), 3 – 5 . https://doi.org/10.12861/jrip.2012.02 

    상세보기

73. Rastegarpanah , M. , Malekzadeh , R. , Vahedi , H. , Mohammadi , M. , Elahi , E. , Chaharmahali , M. , … Abdollahi , M. ( 2015 ). A randomized, double blinded, placebo‐controlled clinical trial of silymarin in ulcerative colitis . Chinese Journal of Integrative Medicine , 21 ( 12 ), 902 – 906 . https://doi.org/10.1007/s11655‐012‐1026‐x 

    상세보기

74. Ross , S. M. ( 2008 ). Milk thistle ( Silybum marianum ): An ancient botanical medicine for modern times . Holistic Nursing Practice , 22 ( 5 ), 299 – 300 . https://doi.org/10.1097/01.HNP.0000334924.77174.6d 

    상세보기

75. Rutter , K. , Scherzer , T. M. , Beinhardt , S. , Kerschner , H. , Stättermayer , A. F. , Hofer , H. , … Ferenci , P. ( 2011 ). Intravenous silibinin as “rescue treatment” for on‐treatment non‐responders to pegylated interferon/ribavirin combination therapy . Antiviral Therapy , 16 ( 8 ), 1327 – 1333 . https://doi.org/10.3851/IMP1942 

    상세보기

76. Sarkar , R. , Arora , P. , Garg , V. K. , Sonthalia , S. , & Gokhale , N. ( 2014 ). Melasma update . Indian Dermatology Online Journal , 5 ( 4 ), 426 – 435 . https://doi.org/10.4103/2229‐5178.142484 

    상세보기

77. Schrieber , S. J. , Hawke , R. L. , Wen , Z. , Smith , P. C. , Reddy , K. R. , Wahed , A. S. , … Fried , M. W. ( 2011 ). Differences in the disposition of silymarin between patients with nonalcoholic fatty liver disease and chronic hepatitis C . Drug Metabolism and Disposition , 39 ( 12 ), 2182 – 2190 . https://doi.org/10.1124/dmd.111.040212 

    상세보기

78. Shahbazi , F. , Sadighi , S. , Dashti‐Khavidaki , S. , Shahi , F. , Mirzania , M. , Abdollahi , A. , & Ghahremani , M. H. ( 2015 ). Effect of silymarin administration on cisplatin nephrotoxicity: report from a pilot, randomized, double‐blinded, placebo‐controlled clinical trial . Pytotherapy Research , 29 ( 7 ), 1046 – 1053 . https://doi.org/10.1002/ptr.5345 

    상세보기

79. Sharifi , R. , Rastegar , H. , Kamalinejad , M. , Dehpour , A. R. , Tavangar , S. M. , Paknejad , M. , … Pasalar , P. ( 2012 ). Effect of topical application of silymarin ( Silybum marianum ) on excision wound healing in albino rats . Acta Medica Iranica , 50 ( 9 ), 583 – 588 . 

    상세보기

80. Stolf , A. M. , Cardoso , C. C. , & Acco , A. ( 2017 ). Effects of silymarin on diabetes mellitus complications: A review . Pytotherapy Research , 31 ( 3 ), 366 – 374 . https://doi.org/10.1002/ptr.5768 

    상세보기

81. Tajmohammadi , A. , Razavi , B. M. , & Hosseinzadeh , H. ( 2018 ). Silybum marianum (milk thistle) and its main constituent, silymarin, as a potential therapeutic plant in metabolic syndrome: A review . Phytotherapy Research , 32 ( 10 ), 1933 – 1949 . https://doi.org/10.1002/ptr.6153 

    상세보기

82. Tamayo , C. , & Diamond , S. ( 2007 ). Review of clinical trials evaluating safety and efficacy of milk thistle ( Silybum marianum [L.] Gaertn.) . Integrative Cancer Therapies , 6 ( 2 ), 146 – 157 . https://doi.org/10.1177/1534735407301942 

    상세보기

83. Ullah , H. , & Khan , H. ( 2018 ). Anti‐Parkinson potential of silymarin: Mechanistic insight and therapeutic standing . Frontiers in Pharmacology , 9 , 422 . https://doi.org/10.3389/fphar.2018.00422 

    상세보기

84. Valentová , K. , Vidlář , A. , Zatloukalová , M. , Stuchlík , M. , Vacek , J. , Šimánek , V. , & Ulrichová , J. ( 2013 ). Biosafety and antioxidant effects of a beverage containing silymarin and arginine. A pilot, human intervention cross‐over trial . Food and Chemical Toxicology , 56 , 178 – 183 . https://doi.org/10.1016/j.fct.2013.02.023 

    상세보기

85. Vargas‐Mendoza , N. , Madrigal‐Santillán , E. , Morales‐González , A. , Esquivel‐Soto , J. , Esquivel‐Chirino , C. , García‐Luna y González‐Rubio , M. , … Morales‐González , J. A. ( 2014 ). Hepatoprotective effect of silymarin . World Journal of Hepatology , 6 ( 3 ), 144 – 149 . https://doi.org/10.4254/wjh.v6.i3.144 

    상세보기

86. Velussi , M. , Cernigoi , A. M. , De Monte , A. , Dapas , F. , Caffau , C. , & Zilli , M. ( 1997 ). Long‐term (12 months) treatment with an anti‐oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients . Journal of Hepatology , 26 ( 4 ), 871 – 879 . https://doi.org/10.1016/S0168‐8278(97)80255‐3 

    상세보기

87. Vidlar , A. , Vostalova , J. , Ulrichova , J. , Student , V. , Krajicek , M. , Vrbkova , J. , & Simanek , V. ( 2010 ). The safety and efficacy of a silymarin and selenium combination in men after radical prostatectomy—A six month placebo‐controlled double‐blind clinical trial . Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia (Biomed Paper) , 154 ( 3 ), 239 – 244 . https://doi.org/10.5507/bp.2010.036 

    상세보기

88. Voroneanu , L. , Nistor , L. , Dumea , R. , & Apetrii , A. ( 2016 ). Silymarin in type 2 diabetes mellitus: A systematic review and meta‐analysis of randomized controlled trials . Journal Diabetes Research , 2016 , 5147468 . 

89. Won , D. H. , Kim , L. H. , Jang , B. , Yang , I. H. , Kwon , H. J. , Jin , B. , … Cho , S. D. ( 2018 ). In vitro and in vivo anti‐cancer activity of silymarin on oral cancer . Tumor Biology , 40 ( 5 ), 1010428318776170 . https://doi.org/10.1177/1010428318776170 

    상세보기

90. Yaghmaei , P. , Azarfar , K. , Dezfulian , M. , & Ebrahim‐Habibi , A. ( 2014 ). Silymarin effect on amyloid‐β plaque accumulation and gene expression of APP in an Alzheimer's disease rat model . Daru , 22 ( 1 ), 24 . https://doi.org/10.1186/2008‐2231‐22‐24 

    상세보기

91. Zhong , S. , Fan , Y. , Yan , Q. , Fan , X. , Wu , B. , Han , Y. , … Niu , J. ( 2017 ). The therapeutic effect of silymarin in the treatment of nonalcoholic fatty disease: A meta‐analysis (PRISMA) of randomized control trials . Medicine (Baltimore) , 96 ( 49 ), e9061 . https://doi.org/10.1097/MD.0000000000009061 

    상세보기

92. Zhu , H. J. , Brinda , B. J. , Chavin , K. D. , Bernstein , H. J. , Patrick , K. S. , & Markowitz , J. S. ( 2013 ). An assessment of pharmacokinetics and antioxidant activity of free silymarin flavonolignans in healthy volunteers: a dose escalation study . Drug Metabolism & Disposition , 41 ( 9 ), 1689 – 1685 .